MUSI, GENNARO
 Distribuzione geografica
Continente #
EU - Europa 12.171
NA - Nord America 4.365
AS - Asia 3.314
SA - Sud America 358
OC - Oceania 58
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 6
Totale 20.313
Nazione #
DE - Germania 7.153
US - Stati Uniti d'America 4.241
CN - Cina 1.408
IT - Italia 1.400
GB - Regno Unito 1.179
SG - Singapore 827
SE - Svezia 773
RU - Federazione Russa 375
BR - Brasile 297
IN - India 277
IE - Irlanda 268
FR - Francia 265
NL - Olanda 255
HK - Hong Kong 222
ID - Indonesia 135
FI - Finlandia 94
KR - Corea 91
CA - Canada 90
TR - Turchia 85
UA - Ucraina 77
DK - Danimarca 76
JP - Giappone 56
AU - Australia 54
VN - Vietnam 54
PH - Filippine 52
AT - Austria 42
BE - Belgio 39
CH - Svizzera 31
ES - Italia 30
EU - Europa 21
MX - Messico 19
RO - Romania 17
PE - Perù 16
NO - Norvegia 15
IR - Iran 14
PL - Polonia 14
CO - Colombia 13
EC - Ecuador 11
GR - Grecia 11
TW - Taiwan 11
AE - Emirati Arabi Uniti 10
EE - Estonia 10
BD - Bangladesh 9
EG - Egitto 9
IL - Israele 9
PT - Portogallo 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
CL - Cile 7
HU - Ungheria 7
MY - Malesia 7
NG - Nigeria 7
AR - Argentina 6
MA - Marocco 6
TH - Thailandia 6
AM - Armenia 5
BO - Bolivia 5
CR - Costa Rica 5
JO - Giordania 5
PK - Pakistan 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AZ - Azerbaigian 4
IQ - Iraq 4
KG - Kirghizistan 4
LT - Lituania 4
NZ - Nuova Zelanda 4
RS - Serbia 4
UZ - Uzbekistan 4
AL - Albania 3
CU - Cuba 3
GT - Guatemala 3
SK - Slovacchia (Repubblica Slovacca) 3
DO - Repubblica Dominicana 2
HR - Croazia 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
SA - Arabia Saudita 2
SC - Seychelles 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
ET - Etiopia 1
IM - Isola di Man 1
IS - Islanda 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
TJ - Tagikistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 20.332
Città #
Frankfurt am Main 6.754
Southend 986
Chandler 676
Singapore 564
Milan 433
Ashburn 282
Dublin 263
Princeton 244
Fairfield 224
Seattle 221
Council Bluffs 218
Beijing 215
Wilmington 174
Santa Clara 142
Ann Arbor 127
Hong Kong 123
Jakarta 116
Houston 111
Cambridge 105
Bengaluru 91
Des Moines 87
Woodbridge 87
Rome 85
Dearborn 82
Shanghai 78
Nanjing 72
Berlin 64
Hyderabad 55
Los Angeles 55
Phoenix 55
New York 53
Guangzhou 49
Helsinki 49
Jinan 47
Mountain View 47
Redmond 41
Jacksonville 37
Toronto 37
Brussels 36
Nuremberg 36
Boardman 35
Turin 33
Shenyang 32
Hebei 29
Redwood City 29
São Paulo 29
Fuzhou 26
Istanbul 26
London 26
Seoul 26
Silver Spring 26
Dong Ket 25
Tianjin 25
Changsha 24
Munich 24
Montreal 23
Amsterdam 22
Tokyo 21
Wuhan 21
San Diego 20
Zhengzhou 20
Hangzhou 19
Serra 19
Naples 18
Cangzhou 17
Quanzhou 17
Vienna 17
Florence 16
Sakarya 16
Nanchang 15
Paris 15
Bühl 14
Central District 14
Chicago 14
Lima 14
Ningbo 14
Rio de Janeiro 14
Sydney 14
Washington 14
Bogotá 13
Fremont 13
Kent 13
Pisa 13
Settimo Milanese 13
Buffalo 12
Düsseldorf 12
Grafing 12
Jiaxing 12
Andover 11
Lappeenranta 11
Manila 11
Pune 11
Somerville 11
Upper Marlboro 11
Zurich 11
Chengdu 10
Eitensheim 10
Genoa 10
Lauterbourg 10
Taizhou 10
Totale 14.284
Nome #
Anatomia del rabdomiosfintere uretrale da preparati anatomici autoptici 569
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 369
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 294
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 290
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 243
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 234
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy 233
Scleroembolizzazione del plesso pampiniforme sec. Marmar modificato in età pediatrica 227
Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer 226
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml 222
Anterior prostatic tumours are difficult to diagnose without MRI 219
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 218
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 204
Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma 201
Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approaches 195
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 193
Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer 193
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 192
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 185
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 179
Robot-assisted simple prostatectomy (RASP) : does it make sense? 176
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 176
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 176
Long-term follow‐up outcomes after percutaneous us/ct‐guided radiofrequency ablation for ct1a‐b renal masses : Experience from single high‐volume referral center 174
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 168
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 167
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 166
High-performance prediction models for prostate cancer radiomics 165
A novel "intuitive" surgical technique for right robot-assisted retroperitoneal lymph node dissection for stage I testicular NSGCT 161
Neoadjuvant chemotherapy for invasive bladder cancer : an interesting case report 160
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 160
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 159
Neoadjuvant chemotherapy for invasive bladder cancer : an interesting case report 157
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 157
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 156
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 155
Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer : A Systematic Diagnostic Attempt 153
Quality of life and psycho-emotional wellbeing in bladder cancer patients and their caregivers: A comparative analysis between urostomy versus ileal orthotopic neobladder 153
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 151
Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses 148
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique : analysis of 542 consecutive patients 148
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 148
Robot-assisted Resection of a Wide-extending Abdominoperineal Angiomyofibroblastoma in a Male Patient 146
Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy : preliminary report 146
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 145
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 145
Robot-assisted intracorporeal orthotopic ileal neobladder : Description of the “shell” technique 144
Parametri prognostici nelle lesioni ecografiche impalpabili del testicolo 143
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 143
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 140
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor 139
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 139
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis : effect on survival and complication rates 139
Beyond PSA : The role of prostate health index (phi) 138
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 137
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 136
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 136
Microchirurgia conservativa delle lesioni testicolari benigne 135
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 134
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 133
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy : a multicenter experience 132
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 131
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 129
Thulium–yttrium–aluminium–garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life 129
Postoperative vacuum therapy following AMS™ LGX 700® inflatable penile prosthesis placement: penile dimension outcomes and overall satisfaction 129
Comparison Between Micro-Ultrasound and Multiparametric MRI Regarding the Correct Identification of Prostate Cancer Lesions 129
Quality assurance for automatically generated contours with additional deep learning 128
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 128
Virtue male sling for post-prostatectomy stress incontinence : a prospective evaluation and mid-term outcomes 128
Robot-Assisted Radical Cystectomy for Nonmetastatic Urothelial Carcinoma of Urinary Bladder: A Comparison between Intracorporeal Versus Extracorporeal Orthotopic Ileal Neobladder 128
Intraoperative radiotherapy for locally advanced prostate cancer : treatment technique and preliminary outcomes 127
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 124
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 124
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 123
Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis 122
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 121
Permanent brachytherapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation 121
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 119
Case series on multiple prostate re-irradiation for locally recurrent prostate cancer: something ventured, something gained 119
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 119
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological Outcomes 117
Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer : prospective longitudinal study in 337 patients 116
Sexual function recovery after robot-assisted radical prostatectomy : outcomes from an Italian referral centre and predicting nomogram 115
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients 115
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 115
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score 114
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette–Guérin after transurethral resection of the bladder tumor 114
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer : A Propensity Score Analysis 113
Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting—prospective single center experience after 300 cases in first biopsy setting 111
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapy 111
Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortality 110
Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes 110
First Live-Experience Session with PET/CT Specimen Imager: A pilot analysis in Prostate Cancer and Neuroendocrine Tumor 109
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis 109
SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features 108
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 106
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma 106
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 104
Uro-oncologic patient management during the COVID-19 pandemic: Survey findings from an Italian oncologic hub 104
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 103
Totale 15.658
Categoria #
all - tutte 62.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020314 0 0 0 0 0 0 0 0 0 162 92 60
2020/20211.409 99 74 65 35 75 173 169 87 256 129 138 109
2021/20221.807 83 90 72 96 200 161 79 114 174 148 138 452
2022/20232.720 333 292 202 214 220 424 186 206 347 44 194 58
2023/20246.429 101 135 129 148 466 267 1.022 890 446 829 983 1.013
2024/20255.680 937 897 808 709 429 355 265 515 307 458 0 0
Totale 21.179